Evidence map›Paper›PMID 36376800›Full record

ArticleBMC bioinformatics2022

iEnhancer-DCLA: using the original sequence to identify enhancers and their strength based on a deep learning framework.

Meng Liao, Jian-Ping Zhao, Jing Tian, Chun-Hou Zheng

Abstract read
In one paragraph

Article in BMC bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. AttnW2V-Enhancer: Leveraging attention and Word2Vec for enhanced enhancer prediction.Computational and structural biotechnology journal · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Meng LiaoCollege of Mathematics and System Sciences, Xinjiang University, Ürümqi, China.
Jian-Ping ZhaoCollege of Mathematics and System Sciences, Xinjiang University, Ürümqi, China. zhaojianping@126.com.
Jing TianCollege of Mathematics and System Sciences, Xinjiang University, Ürümqi, China.
Chun-Hou ZhengCollege of Mathematics and System Sciences, Xinjiang University, Ürümqi, China. zhengch99@126.com.

Funding

the open fund of Information Materials and Intelligent Sensing Laboratory of Anhui Province IMIS202105
6 · The paper itself

Abstract

Enhancers are small regions of DNA that bind to proteins, which enhance the transcription of genes. The enhancer may be located upstream or downstream of the gene. It is not necessarily close to the gene to be acted on, because the entanglement structure of chromatin allows the positions far apart in the sequence to have the opportunity to contact each other. Therefore, identifying enhancers and their strength is a complex and challenging task. In this article, a new prediction method based on deep learning is proposed to identify enhancers and enhancer strength, called iEnhancer-DCLA. Firstly, we use word2vec to convert k-mers into number vectors to construct an input matrix. Secondly, we use convolutional neural network and bidirectional long short-term memory network to extract sequence features, and finally use the attention mechanism to extract relatively important features. In the task of predicting enhancers and their strengths, this method has improved to a certain extent in most evaluation indexes. In summary, we believe that this method provides new ideas in the analysis of enhancers.

Indexed as

Deep LearningEnhancer Elements, GeneticChromatinDNANeural Networks, ComputerChromatinDNAAttention mechanismBidirectional long short-term memory networkConvolutional neural networkEnhancerk-mersWord embedding

Identifiers

PMID36376800
PMCPMC9664816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.